Silk Road Medical

115 articles about Silk Road Medical

• Silk Road Medical to Present at the Stifel 2020 Virtual Healthcare Conference

  11/4/2020

  Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, announced the company will be participating in the upcoming Stifel 2020 Virtual Healthcare Conference.

• Silk Road Medical to Report Third Quarter 2020 Financial Results on November 10, 2020

  10/20/2020

  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the third quarter 2020 after market close on Tuesday, November 10, 2020.

• Silk Road Medical Names Rick Anderson to Board of Directors

  10/1/2020

  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that medical device industry veteran Rick Anderson has joined its board of directors.

• Silk Road Medical Strengthens Leadership Team

  9/21/2020

  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it is strengthening its leadership team with two appointments

• Compelling Outcomes with TCAR vs. CEA in Patients with Carotid Artery Stenosis Published in the Annals of Surgery

  9/21/2020

  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that positive results from the ongoing TransCarotid Artery Revascularization (TCAR) Surveillance Project comparing TCAR and carotid endarterectomy (CEA) have been published in Annals of Surgery1.

• Silk Road Medical to Present at the Morgan Stanley 2020 Healthcare Conference

  9/4/2020

  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming Morgan Stanley 2020 Healthcare Conference. Silk Road Medical’s management is scheduled to present on Friday, September 18 at 11:45 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of t

• ROADSTER 2 Data Publication in Stroke Demonstrates Compelling Patient Outcomes and Strong Safety Profile with TCAR

  8/19/2020

  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that ROADSTER 2 study results have been published in the latest edition of the American Heart Association’s journal, Stroke

• Silk Road Medical Reports Second Quarter 2020 Financial Results

  8/5/2020

  Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, reported financial results for the three months ended June 30, 2020.

• Silk Road Medical to Report Second Quarter 2020 Financial Results on August 5, 2020

  7/23/2020

  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the second quarter 2020 after market close on Wednesday, August 5, 2020. Company management will host a corresponding conference call beginning at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. Investors interested in listening to the conference call may do so by dialing

• Silk Road Medical Promotes Andrew Davis to Newly Created Position of Chief Commercial Officer

  7/9/2020

  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that Andrew Davis has been promoted to Chief Commercial Officer.

• Society for Vascular Surgery (SVS) Issues Guidance on Competence Recommendations for TCAR

  6/30/2020

  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the In-Press release of a clinical competence statement on training and credentialing for TransCarotid Artery Revascularization (TCAR), written by the SVS Writing Committee.

• Silk Road Medical Announces Full Exercise and Closing of Over-Allotment Option

  5/20/2020

  Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today announced that in connection with its previously announced public offering of 6,808,154 shares of its common stock, the underwriters fully exercised and closed on their option to purchase up to an additional 1,021,223 shares of common stock from certain selling securityholders at the public offering price of $39.00 per share,

• Silk Road Medical Announces Closing of Follow-on Public Offering - May 08, 2020

  5/8/2020

  Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, announced the closing of an underwritten public offering of 6,808,154 shares of its common stock at a public offering price of $39.00 per share.

• Silk Road Medical Announces Pricing of Upsized Public Offering - May 06, 2020

  5/6/2020

  Silk Road Medical, Inc. announced the pricing of an underwritten public offering of 6,808,154 shares of its common stock at a public offering price of $39.00 per share, before deducting underwriting discounts and commissions.

• Silk Road Medical Announces Proposed Public Offering of Common Stock - May 05, 2020

  5/5/2020

  Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, announced the commencement of a proposed underwritten public offering of $100 million of shares of its common stock.

• Silk Road Medical Reports First Quarter 2020 Financial Results

  4/30/2020

  Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, reported financial results for the three months ended March 31, 2020.

• Silk Road Medical to Present at the BofA Securities 2020 Health Care Conference

  4/29/2020

  Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, announced the company will be participating in the upcoming BofA Securities 2020 Health Care Conference.

• Silk Road Medical to Report First Quarter 2020 Financial Results on April 30, 2020

  4/21/2020

  Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, announced it will report financial results for the first quarter 2020 after market close on Thursday, April 30, 2020.

• Silk Road Medical Provides COVID-19 Pandemic Update

  4/6/2020

  Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, provided a corporate update in response to the COVID-19 pandemic.

• Silk Road Medical Announces Uplisting to the Nasdaq Global Select Market® - March 05, 2020

  3/6/2020

  Silk Road Medical, Inc. announced that effective as of market open on March 6, 2020, its common stock has been approved for uplisting to the Nasdaq Global Select Market® and will continue trading under its current ticker symbol "SILK".